RespiQ
Leiden, NL · 1 known investors
Find your way into RespiQ
Sign up to see every warm intro you have to RespiQ
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RespiQ team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RespiQ develops a breath analysis device that detects volatile organic compound biomarkers to support early diagnosis and chronic disease management, initially focused on respiratory and gut health conditions such as COPD, food intolerance, SIBO and IBS. The device is offered to healthcare professionals as a hardware-as-a-service, with plans to eventually reach patients and consumers.
Founders & leadership
MG
Mira GleisbergFounder
Investors · 1
Frequently asked questions
- What does RespiQ do?
- RespiQ develops a breath analysis device that detects volatile organic compound biomarkers to support early diagnosis and chronic disease management, initially focused on respiratory and gut health conditions such as COPD, food intolerance, SIBO and IBS. The device is offered to healthcare professionals as a hardware-as-a-service, with plans to eventually reach patients and consumers.
- Who founded RespiQ?
- RespiQ was founded by Mira Gleisberg.
- Who are RespiQ's investors?
- RespiQ's investors include Antler.
- Where is RespiQ headquartered?
- RespiQ is headquartered in Leiden, NL.
